INS and diabetes mellitus: Therefore, we first set out to investigate the influence of validated diabetes-associated gene variants on diabetes progression measured as an increased risk of early redemption of a glucose lowering drug prescription after diagnosis and secondly the increased risk of early redemption of an insulin drug prescription.